4-(anthracen-2-yl)-4-oxobutanoic acid(73693-24-0)
- Name: 4-(anthracen-2-yl)-4-oxobutanoic acid
- Synonyms:
- Molecular Formula:C18H14O3
- Molecular Weight:278.307
- CAS Registry Number:73693-24-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.73693-24-0 4-anthracen-2-yl-4-oxo-butanoic acid
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)]
CAS No.73693-24-0 4-anthracen-2-yl-4-oxo-butanoic acid
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.73693-24-0 4-anthracen-2-yl-4-oxo-butanoic acid
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.73693-24-0 4-(anthracen-2-yl)-4-oxobutanoic acid
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:4-(anthracen-2-yl)-4-oxobutanoic acid
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]

Other Product
- 20026-32-8/1/C11H18N2O/c1-9(2)11(8-14)13-7-10-5-3-4-6-12-10/h3-6,9,11,13-14H,7-8H2,1-2H
- 29781-29-1/(1S)-1α-(β-D-Glucopyranosyloxy)-1,4a,5,7aα-tetrahydro-4aα-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylic acid
- 5264-21-1/1-[(2E)-3-phenylprop-2-en-1-yl]-4-(phenylsulfonyl)piperazine
- 115396-47-9/6-benzyl-2-chloro-9-nitrochromeno[2,3-b][1,5]benzodiazepin-13(6H)-one
- 4895-14-1/8-Bromo-2,6-dimethyl-2-octene
- 70693-31-1/Bicyclo(2.2.1)heptane, 2,2-dimethyl-3-methylene-, distn. residues
- 126380-77-6/L-seryl-L-alanyl-N-[(2S,3S)-3-hydroxy-1-(4-hydroxyphenyl)-6-{[(2S)-1-{[(2S)-1-methoxy-3-methyl-1-oxobutan-2-yl]amino}-3-methyl-1-oxobutan-2-yl]amino}-6-oxohexan-2-yl]-L-alaninamide
- 52833-73-5/Benzo(g)(1)benzothiopyrano(4,3-b)indole, 6,13-dihydro-4-(trifluoromethyl)-
- 64046-48-6/3-phenylpropyl chloroacetate
- 69382-00-9/3-Phenethylcarbazic acid 2-hydroxyethyl ester
- 7424-61-5/(NE)-N-(1-acenaphthen-3-ylpropylidene)hydroxylamine
- 28293-36-9/2,5-bis(4-butylphenyl)-3,6-dichlorocyclohexa-2,5-diene-1,4-dione
- 5763-48-4/4,4-Dimethylcyclopentane-1,3-dicarboxylic acid
- 436100-00-4/3-(5-AMINO-1 H-BENZOIMIDAZOL-2-YL)-PHENOL
- 2170-49-2/1,4-Benzodioxin-2-methanamine,2,3-dihydro-N-[2-(4-methoxyphenoxy)ethyl]-
- 73693-24-0/4-(anthracen-2-yl)-4-oxobutanoic acid
- 65876-33-7/3-[4-(3-aminopropyl)piperazin-1-yl]propan-1-amine
- 86636-92-2/6-ACRYLOYL-2-DIMETHYLAMINONAPHTHALENE
- 82487-99-8/2-ethylbenzyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate
- 23601-41-4/2-Hexenoic acid,4-(2-furanylmethylene)-
- 91375-87-0/2H-1,4-Benzothiazin-3(4H)-one, 6-(2-hydroxy-3-((1-methylpropyl)amino)propoxy)-, (E)-2-butenedioate (1:1) (salt)
- 108793-61-9/DRECHSLEROL A
- 52845-58-6/Pregna-4,6,20-triene-21-carboxylic acid,17-hydroxy-3-oxo-,ç-lactone,(17R)-
- 6202-22-8/MITRAGYNINE
- 13017-05-5/5-amino-3-(1,3-benzodioxol-5-ylmethyl)-4-methyl-1,2,3-oxadiazol-3-ium
- 94580-98-0/Amides, C8-18 and C18-unsatd., N-(2-(2-(2,3-dihydroxypropoxy)ethoxy)ethyl)
- 148685-20-5/Cik1 protein
- 52830-74-7/3-[2,4-bis(dimethylamino)phenyl]-6-(dimethylamino)-3-[4-(dimethylamino)phenyl]phthalide
- 148711-88-0/1-{2,2-dimethyl-5-[3-(4-methylpiperazin-1-yl)propoxy]-2H-chromen-6-yl}ethanone dihydrochloride
- 104778-13-4/Cyclodeca[b]furan-2(3H)-one,9-(b-D-glucopyranosyloxy)-3a,4,5,8,9,11a-hexahydro-6,10-dimethyl-3-methylene-,(3aS,6E,9S,10E,11aR)-